Orthovisc Manufacturer – About Anika Therapeutics

Last Updated On: September 16, 2024

According to the Arthritis Foundation, knee osteoarthritis (OA) affects over 14 million Americans and often results from factors like aging, obesity, and joint injuries. This common condition leads to the deterioration of joint cartilage, resulting in pain, stiffness, and reduced mobility.

One effective treatment option is Orthovisc, a high-molecular-weight hyaluronic acid injection developed by Anika Therapeutics. Known for its innovative orthopedic solutions, Anika Therapeutics focuses on improving patients’ quality of life by alleviating joint pain and enhancing mobility through advanced treatments like Orthovisc.

This article will delve into Anika Therapeutics’ mission, explore its range of products, and examine how Orthovisc is transforming knee osteoarthritis management.

Key Takeaways

• Anika Therapeutics is a leading global medical technology company specializing in developing, manufacturing, and commercializing therapeutic products for tissue protection, healing, and repair. Its strong focus is on advancing joint health. 
• Anika Therapeutics is committed to enhancing patient lives through high-quality, effective medical treatments, guided by values of integrity, excellence, and a patient-first approach.
• The company offers a comprehensive portfolio of products, including Orthovisc, designed to improve mobility and reduce pain by directly targeting joint-related conditions.
• Orthovisc is a high-molecular-weight hyaluronic acid injection designed to relieve pain associated with osteoarthritis. It provides lubrication and cushioning to reduce discomfort and improve joint mobility.

About: Operating since 2016, Med Supply Solutions is known for being one of the industry’s top and trusted suppliers of cosmetic and viscosupplementation products. If you’re looking to buy Orthovisc online, contact our sales department for more information.

Introduction to Anika Therapeutics

Anika Therapeutics is a leading global medical technology company specializing in developing, manufacturing, and commercializing therapeutic products for tissue protection, healing, and repair. As the Orthovisc manufacturer, Anika Therapeutics is renowned for its innovative solutions in joint health.

Anika Therapeutics is committed to enhancing patient lives through high-quality, effective medical treatments. Guided by values of integrity, excellence, and a patient-first approach, the company’s mission is to develop innovative therapies that address unmet medical needs.

With a strong focus on advancing joint health, Anika Therapeutics offers a comprehensive portfolio of products, including Orthovisc, designed to improve mobility and reduce pain. By developing treatments that directly target joint-related conditions, Anika aims to significantly improve the quality of life for those suffering from chronic joint pain.

History of Anika Therapeutics

Anika Therapeutics was established in 1992 with a mission to develop innovative medical treatments that improve patient outcomes. Starting as a small biotech company, Anika focused on harnessing hyaluronic acid technology for therapeutic use, setting the foundation for its future success.

Throughout its journey, Anika Therapeutics has reached several key milestones, including the development of Orthovisc and Monovisc, which have become vital treatments for managing joint pain and osteoarthritis. The company’s IPO in 1997 was pivotal, providing the resources needed to advance its research and development efforts further.

Initially targeting a broad range of medical applications, Anika gradually refined its focus to specialize in joint health. This strategic direction positioned the company as a leader in the field, driving continuous innovation and expanding its product portfolio to better meet the needs of patients with joint conditions. Today, Anika Therapeutics remains dedicated to enhancing joint health with state-of-the-art solutions and therapies.

Expertise in Developing Medical Products

Anika Therapeutics leverages its strong research and development capabilities, which are led by a skilled team of scientists and engineers dedicated to innovation. The company’s significant investment in R&D fuels the continuous enhancement of its products, ensuring they consistently meet the highest standards of safety and efficacy.

The production and manufacturing at Anika Therapeutics utilize cutting-edge technologies and advanced processes to maintain precision and consistency. From sourcing high-quality raw materials to meticulous final packaging, every step is carefully managed to ensure the superior quality of each medical product.

Quality control is a top priority at Anika Therapeutics. Rigorous testing and validation are conducted at every stage of production, ensuring the safety, reliability, and effectiveness of the company’s products. This commitment to stringent quality assurance guarantees that patients receive safe and effective treatments tailored to their medical needs.

Orthovisc

Orthovisc is a high-molecular-weight hyaluronic acid injection designed to relieve pain associated with osteoarthritis. Developed by Anika Therapeutics, Orthovisc mimics the natural synovial fluid in joints, providing lubrication and cushioning to reduce discomfort and improve joint mobility.

Orthovisc is composed of highly purified hyaluronic acid, a substance naturally found in the body. It works by replenishing the depleted hyaluronic acid in arthritic joints, enhancing shock absorption, and minimizing friction between bones. The injection effectively alleviates pain and stiffness, helping patients regain function in affected joints.

Orthovisc is primarily indicated for treating knee osteoarthritis but is also used off-label for other joints, such as the shoulder. Typical treatment involves a series of three to four injections administered one week apart, although the exact Orthovisc dosage and regimen may vary based on individual needs. When considering Orthovisc and how many injections are necessary, clinical guidelines often suggest up to four injections for optimal relief. 

Orthovisc injection reviews frequently highlight significant pain reduction and improved joint function. However, consulting a healthcare provider is essential for personalized advice, especially when exploring options like Orthovisc for shoulder osteoarthritis.

Commitment to Quality and Innovation

Anika Therapeutics upholds rigorous regulatory standards, earning approvals and certifications from leading global health authorities. These credentials underscore the company’s commitment to quality, safety, and efficacy across its product lines.

The company’s strong focus on research and development drives continuous innovation, allowing Anika Therapeutics to expand its product portfolio and address unmet medical needs. By investing in advanced R&D, Anika aims to improve patient outcomes and broaden the therapeutic uses of its products.

Committed to continuous improvement, Anika Therapeutics consistently evaluates and refines its processes to enhance product quality and operational efficiency. This dedication ensures that the company stays at the cutting edge of medical technology, delivering superior solutions that meet the highest standards for patients worldwide.

Other Products and Advancements

Beyond Orthovisc, Anika Therapeutics offers a range of innovative products focused on joint health and tissue repair:

• Monovisc: A single-injection treatment for osteoarthritis knee pain.
• Cingal: Combines hyaluronic acid with a steroid for enhanced, fast-acting pain relief.
• Hyalofast: A biodegradable scaffold that supports cartilage repair and tissue regeneration.
• Tactoset: A bone repair injectable used to treat fractures in bone voids.

These advancements highlight Anika’s dedication to developing comprehensive solutions that improve patient outcomes of joint and soft tissue health.

Conclusion

Anika Therapeutics, the maker of Orthovisc, is dedicated to providing effective solutions for arthritis-related knee pain. With a strong focus on research, quality, and innovation, Anika has grown into a leader in joint health. Their commitment to safety is reflected in their FDA-approved products, which help reduce pain and improve the quality of life for countless individuals.

FAQs

1. Who manufactures Orthovisc?

Anika Therapeutics, a renowned name in the healthcare industry, manufactures Orthovisc.

2. How many injections are typically involved with Orthovisc treatment?

Orthovisc treatment typically involves a series of three to four injections administered weekly. This regimen helps provide optimal relief from joint pain and improve mobility.

3. Has Orthovisc received FDA approval?

Yes, Orthovisc received FDA approval on February 4, 2004, for treating knee osteoarthritis.

References

Orthovisc – Hyaluronic Acid Viscosupplement Treatment For OA Pain – Anika. anika.com. Published January 10, 2022. https://anika.com/medical/products/orthovisc/ 

Orthovisc (Hyaluronan): Side Effects, Uses, Dosage, Interactions, Warnings. RxList. https://www.rxlist.com/orthovisc-drug.htm